Industry Insights
The global hypodermic needles market was estimated at USD 2,568.7 million in 2016. The primary factors attributing to market growth is the implementation of stringent regulations by several governments to confine needlestick injuries.
These laws focus on the enhanced use of safety needles to protect healthcare workers and medical practitioners from needlestick injuries and related infectious diseases. Hypodermic needles refer to the hollow needles with hypodermic syringes that is essential to minimize the contamination during the transfer of the samples into a sterile substrate.
U.S. hypodermic needles market revenue, by end user, 2014 - 2024 (USD Million)
Factors such as increasing awareness concerning regular vaccination and pathological blood testing followed by rising demand for hormone supplements such as insulin will drive the introduction of safe and effective needles. This, in turn, would increase the acceptance and uptake of hypodermic needles in near future.
Inappropriate disposal of the needle is a primary concern, which in turn is expected to increase the demand for advanced engineered mechanisms rendering efficient and safe disposal. As per the data enumerated by World Health Organization (WHO), worldwide there are more than 16 billion injections administered annually. There are numerous benefits associated with the use of safety needles such as user-friendliness during injection, and efficient transfer of medications are resulting in their increased acceptance among medical practitioners.
Segmentation By Needle Type
• Safety
• Non-safety
In 2016, safety needle held more significant market share and is expected to maintain its significant share over the projected period. Introduction of user-friendly features in hypodermic needles and growing awareness of safety needle among the patients and healthcare providers is propelling the demand for safety needle over the forecast period.
Increasing incidence of needlestick injuries and use of needle and syringes in drug delivery is expected to boost the market for safety needles. Moreover, increasing use of safety needle in emerging economies resultant from the rising hygienic healthcare practices is projected to provide a lucrative opportunity for the market growth. However, focus on the introduction of needle-free mechanisms coupled with the automated medication dispensing might restrain the market growth.
According to the Needlestick Safety and Prevention Act, mandated to implement formal written exposure control plans and actively involve frontline healthcare workers (HCWs), while choosing safe needle devices. Furthermore, this act requires employers to create and maintain sharps injury logs comprising detailed information on the type, brand, and manufacturer of devices associated with such injuries. Such obligatory regulations will hugely impact the accessibility of the safety needles and will result in increased uptake in the coming years.
Segmentation By End-User
• Hospital & Clinics
• Diagnostic labs
• Homecare
Hospital & Clinics segment held the significant market share in 2016, growing at a CAGR of 6.4% from 2017 – 2024. This is attributed to the increasing immunization and rising prevalence of infectious diseases. However, homecare segment is anticipated to record highest CAGR owing to the shift from hospital-centric care to home care.
Increasing geriatric population is expected to boost the market for homecare segment in the forecast period. Furthermore, homecare health services render convenience for old aged and mobility impaired patients who cannot visit hospitals frequently. Automated safety needles are safe, efficient and user-friendly, and minimizes the interference of medical practitioners. Thus, safety features coupled with ease of use and disposal of these devices has led to shifting from hospital to home care.
Segmentation By Region
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• Japan
• China
• India
• Central & South America
• Brazil
• Middle East & Africa
In 2016, North America dominates the market with around more than 40% market share. The larger share of the region is due to the increase in the sale of the safety needles with advanced engineered mechanisms.
Increasing awareness among the people regarding deadly infectious diseases and well established hygienic practices has led to increasing in demand for safety needles. Also, several hospitals & clinics are opting for the use of automated and semi-automated safety needles instead of conventional safety needles which in turn is expected to boost the demand for mechanized safety needles over the forecast period.
Asia Pacific is expected to exhibit fastest growth rate in the forecast period. Use of improved and safe needles followed by increasing awareness about the hygienic practices, rising geriatric population and increasing diabetic population in China and India is expected to drive the hypodermic needle market growth in the projected period.
Competitive Landscape
The global hypodermic needle market is dominated by major players such as Becton, Dickinson, and Company, Medtronic plc, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation and Smiths Medical. Some of the other players present are Hindustan Syringes & Medical Devices Limited, Albert David, DeRoyal, Medline Industries, Inc., Hi-Tech Syringes, Nipro Medical Corporation, International Medsurg Connection, Unilife Corporation, Vita Needle Company, and Vygon.
